Table 1 Clinical characteristics of the study cohort
Characteristics | total study population (n = 25) |
|---|---|
Age [years]: median (range) | 57 (18–78) |
Sex: | |
Female n (%) | 6 (24) |
Male n (%) | 19 (76) |
Etiology of portal hypertension: | |
Cirrhotic portal hypertension n (%) | 12 (48.0) |
Emergency variceal hemorrhage n (%) | 6 (50.0) |
Child–Pugh Score A n, (median, range) | 4 (5.5, 5.0–6.0) |
Child–Pugh Score B n, (median, range) | 4 (7.5, 7.0–9.0) |
Child–Pugh Score C n, (median, range) | 4 (14.0, 12.0–15.0) |
Bilirubin level: median (range), mg/dl | 2.75 (0.2–10.2) |
MELD Score: median (range) | 19.0 (8.0–32.0) |
CLIF-C ACLF score: median (range) | 42.5 (20.0–71.0) |
Non-cirrhotic portal hypertension n (%) | 13 (52.0) |
Emergency variceal hemorrhage n (%) | 7 (53.9) |
Myeloproliferative neoplasia n (%) | 6 (46.1) |
Idiopathic portal vein thrombosis n (%) | 4 (30.8) |
Pancreatic cancer n (%) | 1 (7.7) |
Chronic myeloid leukemia n (%) | 1 (7.7) |
Chronic pancreatitis n (%) | 1 (7.7) |